How to Value a Physical Therapy Franchise in 2026

Physical therapy franchises occupy a unique space in healthcare M&A. They combine the recurring revenue dynamics of a healthcare practice with the scalability constraints of a franchise system. I've advised on PT franchise transactions involving ATI, CORA Health Services, Athletico, and several smaller franchise systems, and the valuation mechanics are different enough from independent PT practices that they deserve their own analysis.

The short version: franchise PT operations trade at a discount to independent practices at the single-clinic level, but multi-unit franchise operators can command significant premiums due to the built-in expansion playbook. Here's how the math works.

The PT Franchise Landscape in 2026

The physical therapy franchise market has consolidated significantly. ATI Physical Therapy (now publicly traded, though it went through a restructuring) operates 900+ clinics. CORA Health Services has 350+ locations across the Southeast. Athletico has 600+ clinics in the Midwest. Smaller franchise systems — FYZICAL Therapy & Balance Centers, ApexNetwork Physical Therapy, and PT Solutions (franchise model alongside corporate clinics) — round out the landscape.

What makes PT franchises interesting from a valuation perspective is the therapist productivity model. Unlike a dental practice where the owner-dentist is the primary producer, a PT franchise often has 3-8 treating therapists per location. The owner may or may not be a licensed PT. That operating structure changes the economics — and the multiples.

What PT Franchises Sell For

Based on transactions in the physical therapy space, here are the ranges I see consistently:

• Single-clinic franchise, owner is treating PT: 2.5-4.0x SDE. The lower end is for clinics with declining visit volumes or unfavorable payer mix. The higher end applies to clinics in growth markets with strong physician referral networks.
• Single-clinic franchise, owner is non-clinical:4.0-6.0x EBITDA. When the owner isn't treating, you value on EBITDA because the business already operates with employed providers. This is inherently more transferable.
• Multi-unit operator (3-8 clinics): 6.0-9.0x EBITDA. At this scale, you have centralized scheduling, shared administrative staff, and a regional reputation. These operations attract strategic acquirers and PE-backed platforms.
• Large multi-unit (10+ clinics): 8.0-12.0x EBITDA. Operators at this level are platform acquisition candidates. The infrastructure — clinical directors, compliance systems, payer contracts — makes them immediately accretive to a larger platform.

For comparison, independent PT practices in similar revenue ranges typically trade at 4-7x EBITDA, without the royalty drag. The franchise discount at the single-clinic level is real, but the multi-unit premium can more than offset it.

Therapist Productivity: The Core Metric

In every PT franchise valuation I've worked on, the conversation comes back to visits per therapist per day. This is the metric that drives revenue, determines staffing needs, and ultimately sets your profitability.

Industry benchmarks for PT productivity:

• Below average: 8-10 visits/therapist/day
• Average: 10-12 visits/therapist/day
• Above average: 12-14 visits/therapist/day
• Top performers: 14-16 visits/therapist/day (usually with PTA support)

A clinic running 4 therapists at 12 visits/day generates roughly 240 visits/week. At an average reimbursement of $100-$130 per visit (blended across payers), that's $24,000-$31,200 in weekly revenue, or roughly $1.25M-$1.6M annualized. The same clinic at 9 visits/day drops to $936K-$1.2M. That productivity gap translates directly to a 25-35% difference in valuation.

Buyers will examine your visits-per-therapist-per-day trend over 24 months. A declining trend suggests burnout, referral source loss, or market saturation. An improving trend suggests operational improvements or growing demand. Trend matters as much as the absolute number.

Payer Mix: Why It Matters More in Franchise Markets

Payer mix is critical in any PT practice valuation, but franchise operations face a specific wrinkle: the franchisor often negotiates centralized payer contracts that apply to all franchisees. This can be a benefit (better rates through volume leverage) or a constraint (you can't negotiate your own rates with local payers).

The payer mix tiers that drive PT franchise value:

• Workers' compensation:Highest reimbursement ($130-$180/visit average), but volatile volume and slower payment cycles. Clinics with 20-30% workers' comp revenue see higher margins but more risk.
• Commercial insurance (BCBS, Aetna, UHC): Solid reimbursement ($100-$140/visit), predictable volume. This is the sweet spot for valuation — buyers love a 50%+ commercial mix.
• Medicare: Lower reimbursement ($80-$105/visit under MPFS), subject to annual fee schedule changes and therapy caps (now repealed but replaced with targeted review thresholds). A heavy Medicare mix (40%+) lowers multiples because of regulatory risk.
• Medicaid: Lowest reimbursement ($55-$80/visit), and some states require prior authorization for every visit. A Medicaid-heavy clinic is the hardest to sell at any reasonable multiple.

The Franchisor Support vs. Royalty Tradeoff

PT franchise royalties typically run 5-7% of gross revenue, plus a marketing fund of 1-2%. On a $1.5M clinic, that's $90K-$135K annually. The question every buyer asks is: what do you get for that money?

What good franchise support looks like: centralized billing and collections (PT billing is notoriously complex), EMR/practice management systems, payer contract negotiation, marketing support, clinical training programs, and compliance infrastructure. If the franchisor handles billing and collections well, that alone can be worth 3-5% of revenue in avoided overhead and improved collection rates.

What poor franchise support looks like:a brand name and little else. If you're handling your own billing, marketing, and payer negotiations, you're paying royalties for a name. Buyers will compare your net margins to independent practices and question the franchise value proposition.

I worked on a FYZICAL franchise sale where the franchisor's centralized billing team collected at 96% of billed charges versus the industry average of 85-90%. That 6-11 point collection rate improvement on a $1.8M revenue clinic translated to $108K-$198K in additional annual revenue — more than covering the royalty. The buyer saw the franchise system as a value-add, and the multiple reflected it.

Multi-Unit Operators: Where the Real Value Lives

The economics of PT franchise ownership transform at the multi-unit level. Here's why multi-unit PT franchise operators are especially attractive to acquirers:

Clinical director leverage. A single-clinic owner needs a clinic director (often themselves). A 5-clinic operator needs one regional clinical director overseeing 5 clinic leads. The management overhead per clinic drops significantly, and EBITDA margins typically run 18-25% for multi-unit versus 12-18% for single-clinic operations.

Referral network depth. Multi-unit operators cover more geographies, which means relationships with more orthopedic surgeons, primary care physicians, and sports medicine doctors. A broader referral network is more defensible and more valuable.

De novo expansion optionality. If the franchise agreement allows additional territory development, a multi-unit operator has a proven playbook for opening new clinics. Buyers pay for this optionality because it represents organic growth without acquisition risk.

I've seen a 6-clinic Athletico franchise operator sell for 9x EBITDA to a PE-backed platform. The same clinics, sold individually, would have fetched 4-5x each. The platform premium was real: $2.8M in additional enterprise value from operating as a group rather than six standalone clinics.

Key Value Drivers and Risks

What increases your PT franchise value:

• Therapist productivity above 12 visits/day with low turnover
• Commercial payer mix above 50% of revenue
• Strong physician referral relationships (documented, not just personal)
• Long remaining franchise term with renewal options
• Territory in a growth market (population growth, aging demographics)
• Non-compete agreements with all treating therapists

What kills your value:

• Therapist turnover above 25% annually — recruiting costs eat margins
• Heavy Medicare/Medicaid mix with reimbursement pressure
• Declining visit volume trends over 12+ months
• Franchise agreement restrictions on buyer qualifications
• Single referral source concentration (one surgeon driving 30%+ of visits)
• Compliance issues — PT is heavily audited, and past billing irregularities scare buyers

The Bottom Line

Physical therapy franchise valuation requires understanding both healthcare practice economics and franchise system dynamics. Single-clinic franchise owners should expect 2.5-6x depending on whether the owner treats or not, with the franchise agreement term as a critical variable. Multi-unit operators can command 6-12x EBITDA, especially if they've built management infrastructure and maintained strong therapist productivity. The franchisor's support quality — particularly in billing and payer contracting — either justifies the royalty or it doesn't, and buyers will figure out which one applies to your operation quickly.